Shire pays Insmed 11.5 million. Hercules buys warrants from Insmed for approximately 10 million netting 20 million bucks while continuing to receive interest only payments from INSM through year end 2013. All this occurs on the same day, and Insmed is 21.5 million dollars richer. Now Increlex has hit the skids (btw I knew this one was coming for a while now - it was in Ipsen's earnings report filing), and Iplex is there to pick up the pieces? Phase 3 data and Russell rebalancing are just around the corner, and I thought it was this month on the latter, but historian posted that it's actually in June this year. If that's the case, then I jumped the gun with my prediction, and this is the month that the funds jump in ahead of time to prenegotiate. Help me on that historian if I'm wrong.